ABOUT APTUIT - THE PAST and NOW the present as an evotec company

Established in 2004, Aptuit operated as a privately owned pharmaceutical services provider for thirteen years until  it became an Evotec company in August 2017.

As a member company of Evotec, Aptuit offers a complete set of integrated drug development solutions by applying scientific excellence, outstanding service and a team of some of the foremost scientific professionals in the industry.

Evotec is a drug discovery alliance and development partnership company focused on rapidly progressing innovative product approaches with leading pharmaceutical and biotechnology companies, academics, patient advocacy groups and venture capitalists. It has about 3,000 employees worldwide, with operating sites in Abingdon and Manchester (UK), Cologne, Goettingen and Munich (Germany), Branford, Princeton, Seattle and Watertown (USA), Lyon and Toulouse (France) and Verona (Italy). The Company’s headquarters are located in Hamburg, Germany. 

To learn more....

Visit Evotec homepage                                              Read Evotec Statement on COVID-19

aptuit capabilities

The broad range of integrated capabilities includes:

Integrated Chemistry, Manufacturing and Controls

Integrated CMC overview  

API

  • API route scouting, process development and scale-up
  • API manufacturing
Material sciences 
  • Materials characterisation
  • Polymorph screening/salt selection
Analytical development and QC 
  • Stability Studies – ASAP protocols
  • Compliance and Informatic systems
Pre-clinical formulation   
  • Formulation screening
  • Supply for GLP-studies
Drug Product Development and Manufacturing  
  • Formulation screening and optimisation
  • Process scale-up and technology transfer
  • Clinical DP
  • Commercial DP
   

Integrated Preclinical Development

Integrated Preclinical Development overview  
Safety Assessment

ADME

Pathology Abuse Liability Assessment
Bioanalysis  
   

INDiGO | Best-in-class candidate selection and IND-enabling solutions

INDiGO and INDiGO-Select are Evotec's integrated drug development solutions to de-risk and accelerate your IND-enabling programs

Learn more about INDiGO

 

INDiGO on LinkedIn

 

Aptuit’s offerings also include due diligence and consultancy services.

Sites

We operate from Verona (Italy) and Abingdon, Oxfordshire (UK)

Aptuit sites

 

If you wish to learn more about Evotec's core competencies and partnered Drug Discovery and Development solutions, you can visit our website and if you prefer to talk to our experts view the contact information below.

Visit Evotec homepage

PRIVACY STATEMENT

Read the privacy statement here

Contact information

If you wish to speak to our Business Development team, please fill out the contact form below or send a message to info@evotec.com

For information about career opportunities, please visit our Company career page.

Contact us